Search Results 351-360 of 12907 for immunosuppressant drugs

  1. Matthew S. Block, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Block's translational research is identifying genes and proteins that lead to pathologic inflammation and immunosuppression in cancer patients. The goal of ...

  2. Durvalumab (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is also used alone to treat limited-stage small cell lung cancer (LS-SCLC) that cannot be removed by surgery in patients who have received other ...

  3. Christine L. Snozek, Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Therapeutic drug monitoring, particularly transplant immunosuppression · LC-MS/MS quantitation of clinical analytes · Optimizing laboratory support of clinical ...

  4. Dapsone (oral route) - Side effects & dosage - Mayo Clinic

    Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for ...

  5. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, work ...

  6. Daunorubicin (intravenous route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Pertuzumab (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is also used with other cancer medicines (eg, trastuzumab) as a neoadjuvant treatment (before surgery) of HER2-positive, locally advanced (cancer ...

  8. John Joerns, M.D. - Doctors and Medical Staff - Mayo Clinic

    Drugs & Supplements · Healthy Lifestyle · Mayo Clinic ... Evolving immunosuppressant regimens for use in solid organ transplant ... Activities and honors ...

  9. Pembrolizumab (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is also given to patients whose tumors express PD-L1 or patients who have received other cancer medicines (eg, platinum) that did not work well.

  10. Discovery's Edge: Moments of Discovery - Mayo Clinic News Network

    Curiosity, unconventional thinking, and random chance drive research into new drugs for the treatment of kidney disease. ... immunosuppressive therapy together.”.